BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 1827931)

  • 1. Hormonal therapy before surgical treatment for uterine leiomyomas.
    Moghissi KS
    Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
    Schneider D; Golan A; Bukovsky I; Pansky M; Caspi E
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):540-1. PubMed ID: 1831252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
    Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
    Saltiel E
    Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotrophin-releasing hormone agonist and laparoscopic myomectomy.
    Dubuisson JB; Lecuru F; Foulot H; Mandelbrot L; Bouquet de la Jolinière J; Aubriot FX
    Clin Ther; 1992; 14 Suppl A():51-6. PubMed ID: 1535022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog.
    Hutchins FL
    J Reprod Med; 1992 Aug; 37(8):699-702. PubMed ID: 1432986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of uterine leiomyomas and hirsutism with nafarelin.
    Monroe SE; Andreyko J
    J Reprod Med; 1989 Dec; 34(12 Suppl):1029-33. PubMed ID: 2533618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone agonist use before hysterectomy.
    Stovall TG; Summit RL; Washburn SA; Ling FW
    Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroids (uterine myomatosis, leiomyomas).
    Lethaby A; Vollenhoven B
    Clin Evid; 2005 Dec; (14):2264-82. PubMed ID: 16620489
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.
    Adamson GD
    Am J Obstet Gynecol; 1992 Feb; 166(2):746-51. PubMed ID: 1531577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of uterine fibroids with GnRH-analogues prior to hysterectomy.
    Stjernquist M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():94-7. PubMed ID: 9225649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presurgical treatment of uterine fibroids by using gonadotropin-releasing hormone agonists.
    Falsetti L; Mazzani MD; Rubessa S; Ruggeri C
    Acta Eur Fertil; 1992; 23(1):29-32. PubMed ID: 1293897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leuprolide acetate treatment and myoma arterial size.
    Rutgers JL; Spong CY; Sinow R; Heiner J
    Obstet Gynecol; 1995 Sep; 86(3):386-8. PubMed ID: 7651647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy.
    Al-Shabibi N; Chapman L; Madari S; Papadimitriou A; Papalampros P; Magos A
    BJOG; 2009 Apr; 116(5):681-7. PubMed ID: 19191779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GnRH agonists in the treatment of uterine leiomyomas.
    Bianchi S; Fedele L
    Acta Eur Fertil; 1989; 20(1):5-10. PubMed ID: 2675524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial.
    Mavrelos D; Ben-Nagi J; Davies A; Lee C; Salim R; Jurkovic D
    Hum Reprod; 2010 Sep; 25(9):2264-9. PubMed ID: 20663795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
    Friedman AJ; Hoffman DI; Comite F; Browneller RW; Miller JD
    Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata.
    Schlaff WD; Zerhouni EA; Huth JA; Chen J; Damewood MD; Rock JA
    Obstet Gynecol; 1989 Dec; 74(6):856-62. PubMed ID: 2511532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
    Andreyko JL; Blumenfeld Z; Marshall LA; Monroe SE; Hricak H; Jaffe RB
    Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.